HighTower Advisors’s Veracyte VCYT Stock Holding History

HighTower Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,630	Closed	-$659K	–	4064
2024 Q4	$659K	Buy	16,630 +305	+2%	+$11.5K	﹤0.01%	2264
2024 Q3	$554K	Buy	+16,325	New	+$459K	﹤0.01%	2328
2019 Q2	–	Sell	-17,400	Closed	-$435K	–	2518
2019 Q1	$435K	Buy	+17,400	New	+$332K	﹤0.01%	1530
2015 Q2	–	Sell	-10,937	Closed	-$80K	–	1726
2015 Q1	$80K	Hold	10,937	–	–	﹤0.01%	1513
2014 Q4	$106K	Hold	10,937	–	–	﹤0.01%	1472
2014 Q3	$107K	Hold	10,937	–	–	﹤0.01%	1429
2014 Q2	$187K	Buy	+10,937	New	+$157K	﹤0.01%	1417

Other funds holding VCYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

HighTower Advisors's VCYT Position: Q1 2025 in Review

HighTower Advisors sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 16,630 shares — an estimated $659K sold.

HighTower Advisors first reported a position in VCYT in Q2 2014 and held it in 7 quarters. The position peaked at $659K in Q4 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

HighTower Advisors reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
HighTower Advisors sold 16,630 Veracyte shares in Q1 2025, an estimated $659K.
HighTower Advisors first reported a position in Veracyte in Q2 2014 and held it in 7 quarters.
HighTower Advisors's Veracyte position peaked at $659K in Q4 2024.
287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.